In vitro study on the effect of leonurine hydrochloride on the enzyme activity of cytochrome P450 enzymes in human liver microsomes

References

• Bahar MA, Setiawan D, Hak E, Wilffert B. 2017. Pharmacogenetics of drug-drug interaction and drug-drug-gene interaction: a systematic review on CYP2C9, CYP2C19 and CYP2D6. Pharmacogenomics. 18(7):701–739.
   PubMed Web of Science ®Google Scholar
• Gorski JC, Jones DR, Wrighton SA, Hall SD. 1994. Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily. Biochem Pharmacol. 48(1):173–182.
   PubMed Web of Science ®Google Scholar
• Hakkola J, Hukkanen J, Turpeinen M, Pelkonen O. 2020. Inhibition and induction of CYP enzymes in humans: an update. Arch Toxicol. 94(11):3671–3722.
   PubMed Web of Science ®Google Scholar
• Hicks JK, Bishop JR, Sangkuhl K, Müller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, Skaar TC, et al. 2015. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors. Clin Pharmacol Ther. 98(2):127–134.
   PubMed Web of Science ®Google Scholar
• Hohmann N, Haefeli WE, Mikus G. 2016. CYP3A activity: towards dose adaptation to the individual. Expert Opin Drug Metab Toxicol. 12(5):479–497.
   PubMed Web of Science ®Google Scholar
• Jin M, Li Q, Gu Y, Wan B, Huang J, Xu X, Huang R, Zhang Y. 2019. Leonurine suppresses neuroinflammation through promoting oligodendrocyte maturation. J Cell Mol Med. 23(2):1470–1485.
   PubMed Web of Science ®Google Scholar
• Kato H. 2020. Computational prediction of cytochrome P450 inhibition and induction. Drug Metab Pharmacokinet. 35(1):30–44.
   PubMed Web of Science ®Google Scholar
• Klomp F, Wenzel C, Drozdzik M, Oswald S. 2020. Drug-drug interactions involving intestinal and hepatic CYP1A enzymes. Pharmaceutics. 12(12):1201.
   PubMed Web of Science ®Google Scholar
• Li YY, Lin YK, Liu XH, Wang L, Yu M, Li DJ, Zhu YZ, Du MR. 2020. Leonurine: from gynecologic medicine to pleiotropic agent. Chin J Integr Med. 26(2):152–160.
   PubMed Web of Science ®Google Scholar
• Li G, Simmler C, Chen L, Nikolic D, Chen SN, Pauli GF, van Breemen RB. 2017. Cytochrome P450 inhibition by three licorice species and fourteen licorice constituents. Eur J Pharm Sci. 109:182–190.
   PubMed Web of Science ®Google Scholar
• Li X, Yuan FL, Zhao YQ, Chen FH, Lu WG, Li CW, Li JP. 2011. Effects of leonurine hydrochloride on medically induced incomplete abortion in early pregnancy rats. Eur J Obstet Gynecol Reprod Biol. 159(2):375–380.
   PubMed Web of Science ®Google Scholar
• Li X, Yuan FL, Zhao YQ, Lu WG, Li CW, He CH. 2013. Effect of leonurine hydrochloride on endothelin and the endothelin receptor-mediated signal pathway in medically-induced incomplete abortion in rats. Eur J Obstet Gynecol Reprod Biol. 169(2):299–303.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang S, Liu X, Han D, Xu J, Ma Y. 2018. Neuroprotective effects of leonurine against oxygen-glucose deprivation by targeting Cx36/CaMKII in PC12 cells. PLoS One. 13(7):e0200705.
   PubMed Web of Science ®Google Scholar
• Lolodi O, Wang YM, Wright WC, Chen T. 2017. Differential regulation of CYP3A4 and CYP3A5 and its implication in drug discovery. Curr Drug Metab. 18(12):1095–1105.
   PubMed Web of Science ®Google Scholar
• Magliocco G, Thomas A, Desmeules J, Daali Y. 2019. Phenotyping of human CYP450 enzymes by endobiotics: current knowledge and methodological approaches. Clin Pharmacokinet. 58(11):1373–1391.
   PubMed Web of Science ®Google Scholar
• Mao F, Zhang L, Cai MH, Guo H, Yuan HH. 2015. Leonurine hydrochloride induces apoptosis of H292 lung cancer cell by a mitochondria-dependent pathway. Pharm Biol. 53(11):1684–1690.
   PubMed Web of Science ®Google Scholar
• Miao LL, Zhou QM, Peng C, Liu ZH, Xiong L. 2019. Leonurus japonicus (Chinese motherwort), an excellent traditional medicine for obstetrical and gynecological diseases: a comprehensive overview. Biomed Pharmacother. 117:109060.
   PubMed Web of Science ®Google Scholar
• Ono S, Hatanaka T, Hotta H, Tsutsui M, Satoh T, Gonzalez FJ. 1995. Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1. Pharmacogenetics. 5(3):143–150.
   PubMedGoogle Scholar
• Parvez MK, Rishi V. 2019. Herb-drug interactions and hepatotoxicity. Curr Drug Metab. 20(4):275–282.
   PubMed Web of Science ®Google Scholar
• Polasek TM, Elliot DJ, Miners JO. 2006. Measurement of human cytochrome P4501A2 (CYP1A2) activity in vitro. Curr Protoc Toxicol. Supplement 27:4.19.1–4.19.11.
   PubMedGoogle Scholar
• Shang X, Pan H, Wang X, He H, Li M. 2014. Leonurus japonicus Houtt.: ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine. J Ethnopharmacol. 152(1):14–32.
   PubMed Web of Science ®Google Scholar
• Sudsakorn S, Bahadduri P, Fretland J, Lu C. 2020. 2020 FDA Drug-drug interaction guidance: a comparison analysis and action plan by pharmaceutical industrial scientists. Curr Drug Metab. 21(6):403–426.
   PubMed Web of Science ®Google Scholar
• Tang W, Stearns RA, Wang RW, Chiu SH, Baillie TA. 1999. Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac. Chem Res Toxicol. 12(2):192–199.
   PubMed Web of Science ®Google Scholar
• Walsky RL, Obach RS. 2004. Validated assays for human cytochrome P450 activities. Drug Metab Dispos. 32(6):647–660.
   PubMed Web of Science ®Google Scholar
• Wang M, Jiang W, Zhou J, Xue X, Yin C. 2020. Anemarsaponin BII inhibits the activity of CYP3A4, 2D6, and 2E1 with human liver microsomes. Pharm Biol. 58(1):1064–1069.
   PubMed Web of Science ®Google Scholar
• Zhang X, Feng P, Gao X, Wang B, Gou C, Bian R. 2020. In vitro inhibitory effects of cepharanthine on human liver cytochrome P450 enzymes. Pharm Biol. 58(1):247–252.
   PubMed Web of Science ®Google Scholar
• Zhang L, Li HX, Pan WS, Khan FU, Qian C, Qi-Li FR, Xu X. 2019. Novel hepatoprotective role of Leonurine hydrochloride against experimental non-alcoholic steatohepatitis mediated via AMPK/SREBP1 signaling pathway. Biomed Pharmacother. 110:571–581.
   PubMed Web of Science ®Google Scholar
• Zhang N, Liu J, Chen Z, Dou W. 2019. In vitro inhibitory effects of kaempferitrin on human liver cytochrome P450 enzymes. Pharm Biol. 57(1):571–576.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wen J, Wang G. 2020. Identification of cytochrome P450 isoenzymes involved in the metabolism of 23-hydroxybetulinic acid in human liver microsomes. Pharm Biol. 58(1):60–63.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Cai W, Sha X, Ma G, Zheng Y, Shi X, Zhu Y. 2012. Quantification of leonurine, a novel potential cardiovascular agent, in rat plasma by liquid chromatography-tandem mass spectrometry and its application to pharmacokinetic study in rats. Biomed Chromatogr. 26(4):518–523.
   PubMed Web of Science ®Google Scholar